AI accelerates drug discovery and development through data mining

18 February 2020

Dr. Jackie Hunter, board member of BenevolentAI, discusses its project that targets glioblastoma and how BenevolentAI has used its technology to come up with new hypotheses for therapeutic agents. This video explains why artificial intelligence (AI) will be transformational for drug discovery and drug development and how it can enhance diagnosis to rapidly detect disease such as cancer.

This interview was filmed at SLAS2020 - watch other highlights from the show here >>